Credit Suisse AG Buys 17,333 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Credit Suisse AG grew its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) by 32.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 69,989 shares of the company’s stock after purchasing an additional 17,333 shares during the quarter. Credit Suisse AG owned approximately 0.05% of AdaptHealth worth $1,315,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Trexquant Investment LP purchased a new stake in shares of AdaptHealth during the 2nd quarter valued at about $626,000. Resource Consulting Group Inc. purchased a new stake in shares of AdaptHealth during the 3rd quarter valued at about $2,646,000. TCW Group Inc. purchased a new stake in shares of AdaptHealth during the 3rd quarter valued at about $503,000. Kennedy Capital Management Inc. increased its holdings in AdaptHealth by 10.6% in the 2nd quarter. Kennedy Capital Management Inc. now owns 629,106 shares of the company’s stock worth $11,349,000 after acquiring an additional 60,371 shares in the last quarter. Finally, Arizona State Retirement System increased its holdings in AdaptHealth by 2.9% in the 3rd quarter. Arizona State Retirement System now owns 18,246 shares of the company’s stock worth $343,000 after acquiring an additional 508 shares in the last quarter. Hedge funds and other institutional investors own 86.33% of the company’s stock.

Insider Buying and Selling

In related news, COO Daniel Bunting sold 115,078 shares of the firm’s stock in a transaction on Friday, December 9th. The stock was sold at an average price of $21.94, for a total value of $2,524,811.32. Following the completion of the sale, the chief operating officer now directly owns 183,619 shares in the company, valued at $4,028,600.86. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, insider Everest Hill Group Inc. sold 540,000 shares of AdaptHealth stock in a transaction on Monday, February 6th. The stock was sold at an average price of $20.75, for a total transaction of $11,205,000.00. Following the completion of the sale, the insider now directly owns 12,805,008 shares in the company, valued at $265,703,916. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Daniel Bunting sold 115,078 shares of AdaptHealth stock in a transaction on Friday, December 9th. The stock was sold at an average price of $21.94, for a total value of $2,524,811.32. Following the sale, the chief operating officer now owns 183,619 shares of the company’s stock, valued at $4,028,600.86. The disclosure for this sale can be found here. Insiders sold a total of 1,255,078 shares of company stock worth $25,794,600 over the last three months. 17.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. SVB Securities reduced their target price on shares of AdaptHealth from $30.00 to $23.00 in a report on Wednesday, March 1st. Canaccord Genuity Group increased their price objective on shares of AdaptHealth from $26.00 to $28.00 and gave the company a “buy” rating in a report on Wednesday, November 9th. Robert W. Baird cut their price objective on shares of AdaptHealth from $31.00 to $23.00 and set an “outperform” rating for the company in a report on Wednesday, March 1st. Truist Financial cut their price objective on shares of AdaptHealth from $28.00 to $20.00 in a report on Wednesday, March 1st. Finally, SVB Leerink increased their price objective on shares of AdaptHealth from $29.00 to $30.00 and gave the company an “outperform” rating in a report on Thursday, November 10th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has an average rating of “Buy” and a consensus target price of $25.33.

AdaptHealth Stock Down 0.9 %

Shares of AHCO opened at $14.94 on Thursday. The company has a market cap of $2.01 billion, a PE ratio of 57.46, a P/E/G ratio of 0.67 and a beta of 0.71. The business has a fifty day moving average of $20.23 and a 200 day moving average of $20.46. AdaptHealth Corp. has a 52-week low of $11.40 and a 52-week high of $27.48. The company has a quick ratio of 1.00, a current ratio of 1.28 and a debt-to-equity ratio of 1.00.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.